IL‐34 was high in serum of women with polycystic ovary syndrome and may function as potential diagnostic biomarker and therapeutic target
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Obstetrics and Gynaecology Research"
DOI: 10.1111/jog.15141
Abstract: Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine disorders in females of reproductive age, with a prevalence of 20%–33% in the general population. Interleukin (IL)‐34 is a recently explored proinflammatory cytokine and… read more here.
Keywords: serum women; polycystic ovary; women polycystic; high serum ... See more keywords